Epocrates
For u.S.-based healthcare professionals including physicians, nurse practitioners, and pharmacists requiring rapid drug information at the point of care.
epocrates: Drug Info & Pill ID
Snapshot
Who is Epocrates?
Providing U.S. healthcare professionals with point-of-care clinical decision support tools to improve prescribing safety and efficiency.
Target audience
Portfolio
Free 1Last updated
epocrates: Drug Info & Pill ID
v26.4.0
6mo ago
Publisher DNA
What defines Epocrates?
Publisher DNA
Primary focus
Clinical decision support and medical reference tools
Scale
indie
Target audience
U.S.-based healthcare professionals including physicians, nurse practitioners, and pharmacists requiring rapid drug information at the point of care.
Signature Patterns
- •Focus on high-utility clinical tools including drug interaction checkers and pill identification.
- •Freemium monetization model utilizing a core free tier and a premium 'Epocrates+' subscription.
- •Strict targeting of U.S.-based professional medical practitioners and students.
- •High-frequency update cycle to maintain clinical data accuracy and address technical performance.
Portfolio momentum
Maintains an intense development cadence with 11 updates in the last 6 months for its single flagship medical reference title.
Portfolio
What does Epocrates ship?
Apps
1 app analysed
Unique 30-drug interaction checker and visual Pill ID
- Clinical Utility
- Aggressive Monetization
User Sentiment
How do users feel about their apps?
0
Positive apps
0
Neutral / mixed
1
Negative apps
24/100
Avg sentiment score
Rivals
Who does Epocrates compete with?
The rivals identified
Nemeses(1)
Both apps target the same U.S. healthcare professional audience for bedside clinical decision support, creating direct competition for daily clinical workflow time.
Same space(2)
Full Code targets the same clinical audience as epocrates but shifts the focus from reference data to active skill development through simulation.
Right Decision Service provides clinical decision support tools similar to epocrates but emphasizes validated evidence for both professionals and citizens.
The Analyst's Read
The bottom line on Epocrates
Bottom line
Epocrates is a well-entrenched incumbent in the medical category, but its current trajectory shows a tension between revenue-focused monetization and the reliability required for clinical environments. Its market position is currently sustained by historical dominance rather than high user sentiment.
Frequently asked questions
How many apps does Epocrates publish?
What kind of apps does Epocrates make?
What is Epocrates's top app?
What fed this analysis
- Apps analyzed:
- 1
- With full intel:
- 1
- With overview:
- 1
- Website scraped:
- yes
- Social presence:
- yes